A follow-up study of 100 gastric cancer patients showed that patients with positive MRPS17 expression had a significantly worse prognosis than those with negative expression, and high MRPS17 expression, as an independent prognostic factor, was closely related to the aggressiveness of gastric cancer (74). This evidence concerns the gene MRPS17 and gastric cancer.